Apoptosis in human tumor cells following treatment with p120 antisense oligodeoxynucleotide ISIS 3466

R K Busch1, L Perlaky, B C Valdez

  • 1Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030.

Cancer Letters
|November 11, 1994
PubMed

Insights

Antisense oligonucleotide ISIS 3466 induces apoptosis in HeLa cells, characterized by DNA fragmentation and increased cell death. This finding highlights its potential as a therapeutic agent targeting cancer cells.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Phosphorothioate oligonucleotides are emerging as therapeutic agents.
  • Antisense technology targets specific gene expression.
  • Apoptosis is programmed cell death crucial in development and disease.

Purpose of the Study:

  • To investigate the effects of antisense oligonucleotide ISIS 3466 on HeLa cells.
  • To confirm apoptosis induction by ISIS 3466 in HeLa cells.
  • To compare the efficacy of ISIS 3466 with other oligonucleotides.

Main Methods:

  • Treatment of HeLa cells with ISIS 3466 and other oligonucleotides.
  • Morphological analysis of cells for apoptosis indicators.
  • DNA extraction and agarose gel electrophoresis to detect nucleosomal ladders.
  • Quantification of floating and attached cells to assess toxicity.

Main Results:

  • ISIS 3466 induced apoptosis in HeLa cells, evidenced by nucleosomal DNA fragmentation (laddering).
  • Morphological changes consistent with apoptosis were observed, particularly in detached cells.
  • ISIS 3466 resulted in the highest percentage of floating cells (78.4%), indicating significant toxicity.
  • Other tested oligonucleotides showed lower toxicity and did not induce nucleosomal laddering.

Conclusions:

  • Antisense oligonucleotide ISIS 3466 effectively induces apoptosis in HeLa cells.
  • The percentage of floating cells serves as a reliable indicator of oligonucleotide-induced toxicity.
  • ISIS 3466 demonstrates potent cytotoxic effects on HeLa cells, warranting further investigation for cancer therapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...